Who is a candidate for KEYTRUDA?
KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy.
What cancers is KEYTRUDA approved for?
KEYTRUDA, in combination with chemotherapy, with or without bevacizumab, is indicated for the treatment of patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS ≥1) as determined by an FDA-approved test.21 Mar 2022
What cancers can KEYTRUDA treat?
Keytruda is used alone or with other drugs to treat certain types of breast cancer, skin cancer (squamous cell carcinoma of the skin, Merkel cell carcinoma, and melanoma), colorectal cancer, endometrial cancer, renal cell carcinoma (a type of kidney cancer), esophageal cancer, gastroesophageal junction cancer, stomach
How can diversity be improved in clinical trials?
What can be done to increase diversity in clinical trials? By taking a holistic view of both patient and public health needs, doctors can be integral to improvements in diversification of clinical trial research. Patients would also benefit from more education on clinical trials.
How is clinical trial data collected?
Acquisition or collection of clinical trial data can be achieved through various methods that may include, but are not limited to, any of the following: paper or electronic medical records, paper forms completed at a site, interactive voice response systems, local electronic data capture systems, or central web based
Why are there research studies only for certain age groups?
In the past, trials typically had a guideline of participants between the ages of 18 and 65. Children and the elderly were underrepresented so there may be less data on how these age groups may respond to the drug or treatment being studied.
Why is diversity in clinical trials important?
Why is diversity in clinical trials so important? Different people may have different reactions to the same treatment, based on their age, gender, weight, race, ethnicity, and other factors. Clinical trials rely on volunteers to take part, and it’s vital that these people come from diverse backgrounds.
What does diversity in clinical trials mean?
Different people may have different reactions to the same treatment, based on their age, gender, weight, race, ethnicity, and other factors. Clinical trials rely on volunteers to take part, and it’s vital that these people come from diverse backgrounds.
How are oncology clinical trials different?
Oncology is somewhat more complicated than other therapeutic areas. The endpoints, for one, differ greatly. For example, rather than running a clinical trial to test the safety and efficacy of an antibiotic against an infection, an oncology trial is trying to extend and improve a subject’s quality of life.
What types of cancer respond well to immunotherapy?
So cancers that are especially easily targeted include lung cancers, skin cancers, and some types of colon cancer. We’ve been successful in finding targets on the cancers that right now have approved therapies of immunotherapies that work very well.
What is clinical trial diversity?
Clinical trials are research studies involving human volunteers to evaluate medical products like medications, vaccines, or devices for safety and effectiveness. Ensuring people from diverse backgrounds join clinical trials is key to advancing health equity.6 days ago
Does Merck do clinical trials?
Merck stands at the forefront of research to help prevent and treat diseases that threaten people’s health, by conducting clinical trials. If you’re interested in learning more about clinical trials, explore our website resources and consider browsing our enrolling clinical trials.
How do you collect patient data?
You can collect patient data in several different ways — by conducting an interview in a clinical setting, by having the patient complete a paper form, or by having the patient fill out an online form.24 Apr 2020
What are the methods of data collection in healthcare?
Questionnaires, observations, and document examination are all examples of healthcare data collection techniques. Today, most information is collected through digital channels and a plethora of apps available on the market using market research service.23 Mar 2021
What is the most important reason to participate in a clinical trial?
When you participate in a clinical trial, you are contributing to research that could bring new treatments one step closer to reaching patients across the nation. The trial may not only help advance the science for your disease or illness, but could also make progress for related areas of science.May 5, 2017
Why is it important for older adults and diverse populations to participate in clinical trials?
Age diversity in clinical trials benefits both the patient experience and the success of the trial. It is often the case that elderly subjects are omitted from clinical trials. Consequently, physicians know very little about how a given treatment may affect their older patients.19 Aug 2018
What is Keynote cancer?
KEYNOTE-158: Recruiting This is a multicohort trial investigating up to 2 years of treatment with pembrolizumab 200 mg every 3 weeks across various solid tumors. All participants have unresectable and/or metastatic disease that has progressed on standard of care therapy.
Why clinical trial diversity is important?
This is why diversity among clinical trial participants is so important. The more diverse a group of clinical trial participants, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people who have characteristics like those of the participants.
What is the success rate of immunotherapy for lung cancer?
In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15 percent of people with advanced non-small cell lung cancer live for at least five years — and 25 percent of patients whose tumor cells had a specific protein lived at least that long.
Used Resourses:
- https://www.merckclinicaltrials.com/
- https://oncology.medicinematters.com/non-small-cell-lung-cancer/pembrolizumab/at-a-glance-the-keynote-lung-cancer-trials/13445200
- https://www.cancer.gov/publications/dictionaries/cancer-terms/def/keytruda
- https://www.appliedclinicaltrialsonline.com/view/importance-age-diversity-clinical-trials
- https://www.fda.gov/consumers/minority-health-and-health-equity/clinical-trial-diversity
- https://www.medicalnewstoday.com/articles/278779
- https://www.merck.com/research-and-products/diversity-in-clinical-trials/
- https://www.pharmasug.org/proceedings/2011/IB/PharmaSUG-2011-IB03.pdf
- https://www.jotform.com/blog/patient-data-collection/
- https://pubrica.com/academy/medical-writing/medical-data-collection-challenges-strategies-and-future-impacts-in-healthcare/
- https://en.wikipedia.org/wiki/Clinical_data_acquisition
- https://www.pfizer.com/news/featured_stories/featured_stories_detail/diversity_in_clinical_trials_why_it_s_important
- https://www.merck.com/news/keytruda-pembrolizumab-shows-overall-response-rates-of-73-to-83-percent-with-complete-response-rates-of-27-to-30-percent-in-heavily-pre-treated-patients-with-chl-in-update-to-study-kn-087/
- https://news.cancerconnect.com/lung-cancer/keytruda-doubles-survival-rate-compared-to-chemotherapy
- https://www.uclahealth.org/u-magazine/immunotherapy-improves-five-year-survival-rate-of-people-with-advanced-lung-cancer
- https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-patients-with-msi%E2%80%91h-dmmr-advanced-endometrial-carcinoma-who-have-disease-progression-following-prior-systemic-therapy-in-any-se/
- https://www.webmd.com/cancer/immunotherapy-different-cancers
- https://www.keytrudahcp.com/approved-indications/
- https://www.agingresearch.org/five-reasons-you-should-participate-in-clinical-trials/
- https://meridienresearch.net/research-studies-certain-age-groups/
- https://www.merck.com/research-and-products/diversity-in-clinical-trials/
- https://www.pfizerclinicaltrials.com/about/diversity-in-clinical-trials
